Fails 4 of 8 criteria. S2, prescription gating: The semaglutide and tirzepatide product pages sell each plan with add-to-cart and buy-now buttons, and the care page that follows opens by saying the order is in before the prescription is processed. The eligibility button opens a quiz whose first screen asks what brings the buyer to the practice. 3 more criteria also fail; see the table below.
At a glance
DrBrainRxTelehealth service
4/8criteria passed
Price
Semaglutide $199 a month, tirzepatide $299, plus a $25 monthly care plan
Sells
compounded semaglutide, compounded tirzepatide, and 9 more
Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.
A physician-led telehealth practice founded by a neurologist, selling compounded semaglutide and tirzepatide by monthly or bundled plan, brand-name GLP-1 care through Lilly Direct or insurance, and peptide vials including NAD+, sermorelin, BPC-157 and GHK-Cu. Its product pages take orders with add-to-cart buttons, and it names no pharmacy and no street address.
DrBrainRx's semaglutide page on its leadareligibility storefront; DrBrainRx's tirzepatide page on its leadareligibility storefront; DrBrainRx's website
DrBrainRx's semaglutide page on its leadareligibility storefront; DrBrainRx's tirzepatide page on its leadareligibility storefront; DrBrainRx's skinny brain page; DrBrainRx's new FAQ; DrBrainRx's website; DrBrainRx's BPC-157 page on its leadareligibility storefront; DrBrainRx's sermorelin page on its leadareligibility storefront
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSThe terms say prescription decisions are made solely by the licensed provider after a medical evaluation, and the product pages say each order requires a medical intake and provider review. The practice was founded by Dr. Sara Siavoshi, a board-certified neurologist.Source: DrBrainRx's terms of service page; DrBrainRx's semaglutide page on its leadareligibility storefront; DrBrainRx's about page.
S2FAILThe semaglutide and tirzepatide product pages sell each plan with add-to-cart and buy-now buttons, and the care page that follows opens by saying the order is in before the prescription is processed. The eligibility button opens a quiz whose first screen asks what brings the buyer to the practice.Source: DrBrainRx's semaglutide page on its leadareligibility storefront; DrBrainRx's tirzepatide page on its leadareligibility storefront; DrBrainRx's membership page; DrBrainRx's skinny brain page.
S3FAILNo filling pharmacy is named. The answers say compounded medications are filled through USP-certified pharmacies in the United States, and the terms and shipping policy refer only to licensed partner pharmacies.Source: DrBrainRx's website; DrBrainRx's terms of service page; DrBrainRx's shipping policy.
S4PASSEach compounded product page states that compounded medications are not FDA approved, and the tirzepatide page adds that it is not the FDA-approved brand product. The same pages say compounded semaglutide contains the same active ingredient as the approved brands, and the home page sells compounded GLP-1 with no disclosure.Source: DrBrainRx's semaglutide page on its leadareligibility storefront; DrBrainRx's tirzepatide page on its leadareligibility storefront; DrBrainRx's website.
S5FAILNo certificate of analysis or lot document is published. The product pages describe COA-backed sterility, potency and quality testing with no document behind the claim.Source: DrBrainRx's semaglutide page on its leadareligibility storefront; DrBrainRx's NAD+ page on its leadareligibility storefront.
S6FAILNo street address is printed in the footer, on the contact page, in the terms or in the privacy policy. The privacy policy names Siavoshi, Inc., doing business as DrBrainRx, and the product pages say only that it is based in San Diego, California.Source: DrBrainRx's contact page; DrBrainRx's contact information page; DrBrainRx's privacy policy; DrBrainRx's NAD+ page on its leadareligibility storefront.
S7PASSCompounded semaglutide at $199 a month, $495 for three months or $774 for six months, and compounded tirzepatide at $299 a month, $807 for three months or $1,494 for six months, with a care plan required at $25 a month. NAD+ at $299 a vial, BPC-157 at $280, sermorelin at $260, CJC-1295 with ipamorelin at $270 and GHK-Cu at $285. Brand-name care is $99 a month, with Zepbound from Lilly Direct at $349 for 2.5 mg and $499 for higher doses on the weight loss and answers pages and at $299 and $399 to $449 on the home page. The home page prints semaglutide at $129 and tirzepatide at $249 for all doses, the six-month monthly equivalents, and the weight loss page prints tirzepatide at $299 up to 7.5 mg and $399 above it. A code takes $50 off a new patient's first vial.Source: DrBrainRx's semaglutide page on its leadareligibility storefront; DrBrainRx's tirzepatide page on its leadareligibility storefront; DrBrainRx's skinny brain page; DrBrainRx's new FAQ; DrBrainRx's website; DrBrainRx's BPC-157 page on its leadareligibility storefront; DrBrainRx's sermorelin page on its leadareligibility storefront.
S8PASSNo FDA warning letter names DrBrainRx or Siavoshi, Inc., and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, Zepbound through Lilly Direct, brand-name GLP-1 insurance concierge (Wegovy, Ozempic, Mounjaro, Zepbound), NAD+, sermorelin, BPC-157, CJC-1295 / ipamorelin, GHK-Cu, minoxidil, finasteride, sildenafil and tadalafil, supplements.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.